NVS/(AMGN) report Erenumab (CGRP) data from various studies at American Headache Society: https://globenewswire.com/news-release/2017/06/08/1011167/0/en/Novartis-presents-data-demonstrating-efficacy-of-AMG-334-erenumab-in-migraine-prevention-at-the-American-Headache-Society-Annual-Meeting.html